Clinical Trial Update: Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of bortezomib with gemcitabine and cisplatin in advanced or metastatic non-small cell lung cancer has completed enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University Hospital of Crete | Conditions: Non Small Cell Lung Cancer, Metastatic | Phase 2 | Status: COMPLETED